Facebook
Instagram
Twitter
YouTube
RSS Feed
LinkedIn
Flickr
California Institute for Regenerative Medicine
For Researchers
FUNDING OPPORTUNITIES
Information for Applicants
All Funding Opportunities
COVID-19
Discovery
Translational
Clinical
Infrastructure
Education
Previous Funding Opportunities
GRANTS
Active Awards Portfolio Dashboard
CIRM Grants
Managing Your Grant
CIRM Grantees
CIRM-Funded Institutions
CIRM Funding Commitments
Stem Cell Grant Regulations
CLINICAL RESOURCES
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Cell and Gene Therapy Center
Collaborative Funding Partnerships
RESEARCH RESOURCES
FAQs for CIRM Awards
Industry Alliance Program
iPSC Repository
Genomics Initiative
CIRM Publications
Grantee Publications
Webinars and Workshops
hESC Cell Lines
For Patients
Patient Resources
CIRM Funded Clinical Trials
Alpha Stem Cell Clinics
Stem Cell Champions
Disease Programs
Stories of Hope
CIRM Stem Cellar Blog
Stem Cell Videos
Stem Cell Basics
Stem Cell Key Terms
Creating New Types of Stem Cells
Accelerating Research Towards Cures
California: The Leader in Stem Cell Research
From Lab Bench to Bedside
Myths and Misconceptions About Stem Cell Research
Stem Cell Tourism
The Power of Stem Cells
Patient Toolbox
Get Involved
Talking About CIRM
Jargon-Free Glossary
Media Interviews
Delivering the Perfect Presentation
Moderating a Panel
Serving on a Panel
Participating in Clinical Trials
Our Impact
Impact
Active Awards Dashboard
Funding Clinical Trials
Return on Investment
Creating Jobs
Creating Infrastructure
Growing the Field
Strategic Plan
Education
Internship programs (Bridges & SPARK)
Education Portal
Training Tomorrow's Scientists
Community
Stem Cell Champions
Stem Cell Awareness Day
Get Involved
About CIRM
About Us
Our Mission
Leadership
Our History
2023 Annual Report
CIRM FAQ
Where CIRM funding goes
Job Opportunities
Contact Us
Governing Board
Public Meetings
CIRM Resources
Annual Report Archive
Strategic Plan
Funding Opportunities
Administrative Policies and Forms
News and Events
Newsroom
Meetings & Events
Public Meetings and Events
CIRM Board Meetings
Blog
Multimedia Resources
Podcast
Videos
Images
CIRM Fact Sheet
Logos
Contact Us
All CIRM Grants
Search Filters »
Disease Focus
(All)
aa Multiple Diseases (Centers & Resoures) (14)
Age-related macular degeneration (13)
Aging (22)
Alpha Thalassemia Major (3)
Alzheimer's Disease (35)
Amyotrophic Lateral Sclerosis (57)
Anemia (10)
Angelman Syndrome (1)
Arthritis (14)
Autism (22)
Autoimmune Disorder (1)
B cell cancers (12)
Beta Thalassemia (5)
Bladder or Urinary Tract Disorder (6)
Blood Cancer (73)
Blood Disorders (114)
Bone Marrow Transplant and Viral Infection (7)
Bone or Cartilage Disease (52)
Brain Cancer (35)
Brain Injury, hypoxic, ischemic (2)
Breast Cancer (9)
Canavan Disease (1)
Cancer (167)
Cartilage defect (4)
Colon Cancer (6)
Corneal Damage (7)
COVID-19 (23)
Cystic Fibrosis (3)
Cystinosis (3)
Danon Disease (4)
Dementia (5)
Developmental Disorders (23)
Diabetes (53)
Diabetic Wounds (2)
Duchenne Muscular Dystrophy (4)
Epidermolysis Bullosa (3)
Epilepsy (12)
Fertility (13)
Genetic Disorder (41)
Hearing Loss (11)
Heart Disease (105)
Heart disease associated with Duchenne muscular dystrophy (2)
Heart failure (12)
Hemophilia A (2)
HIV-related Lymphoma (2)
HIV/AIDS (42)
Huntington's Disease (37)
Hyper IgM Syndrome (2)
Hypertension, pulmonary arterial (2)
Immune Disease (57)
Incontinence (2)
Infectious Disease (55)
Inflammatory bowel disease (1)
Intellectual Disability (5)
Intervertebral disc degeneration (2)
Intestinal Disease (16)
IPEX Syndrome (5)
Kidney Disease (17)
Kidney Failure (14)
Leukemia (10)
Leukemia, Acute Myeloid (AML) (23)
Leukocyte Adhesion Deficiency (2)
Liver Disease (22)
Lung Cancer (6)
Lung Disease, Fibrosis (5)
Lupus, Systemic Lupus Erythematosus (SLE) (2)
Melanoma (13)
Metabolic Disorders (89)
Multiple Myeloma (8)
Multiple Sclerosis (9)
Muscle Injury (3)
Muscular Dystrophy (25)
N/A (441)
Neurological Disorders (308)
Neuropathy (5)
Osteoarthritis (6)
Osteonecrosis (3)
Other (19)
Ovarian Cancer (9)
Pancreatic Cancer (4)
Parkinson's Disease (52)
Pediatrics (74)
Prostate Cancer (7)
Pulmonary Hypertension (4)
Respiratory Disorders (28)
Retinitis Pigmentosa (11)
Rett's Syndrome (7)
Sanfilippo Syndrome/MPS III (2)
Sarcoma (4)
Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID) (4)
Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) (4)
Severe Combined Immunodeficiency, X-linked (X-SCID) (8)
Sickle Cell Disease (23)
Skeletal/Smooth Muscle disorders (45)
Skin cancer (2)
Skin Disease (19)
Solid Tumors (93)
Spina Bifida (5)
Spinal Cord Injury (42)
Spinal Muscular Atrophy (9)
Stroke (29)
Tendon/Ligament/Connective Tissue Injury or Disorder (3)
Thymic Disorder, 22q11 Deletion/DiGeorge (1)
Toxicity (7)
Trauma (11)
Traumatic Brain Injury (5)
Type 1 diabetes (21)
Vascular Disease (17)
Vision Loss (66)
Wounds, ulcers (3)
X-linked Chronic Granulomatous Disease (3)
Zika virus (3)
Institution
(All)
AcuraStem Incorporated (2)
Adjuvant Partners, LLC (1)
Adverum Biotechnologies (1)
Ali Nsair (1)
Alliance Forum Foundation (4)
Allogene Therapeutics (1)
Alto Neuroscience (1)
American Association of Blood Banks (2)
American Institute of Chemical Engineers (AIChE) (1)
Angiocrine Bioscience, Inc. (4)
Ankasa Regenerative Therapeutics, Inc. (2)
Aspen Neuroscience (2)
Aspera Biomedicines, Inc. (1)
Axent Biosciences Inc. (1)
Benjamin D. Yu (1)
Berkeley City College (2)
Biocom Institute (1)
BioEclipse Therapeutics INC. (1)
Biomedical Engineering Society (2)
BioTime, Inc. (1)
Bluebird Bio (1)
Boston Children’s Hospital (1)
Brain Mapping Foundation (2)
Brain Neurotherapy Bio (1)
BrainStorm Cell Therapeutics (1)
BrainXell Therapeutics (2)
Buck Institute for Age Research (9)
Cal Poly Corporation, an Auxiliary of California Polytechnic State University, San Luis Obispo (4)
Cal Poly Pomona Foundation (1)
Cal State Univ, Fullerton (4)
Cal State Univ, Long Beach (3)
Cal State Univ, Sacramento (3)
Cal State Univ, San Bernadino (4)
Caladrius Biosciences (2)
Calibr (3)
Calidi Biotherapeutics, Inc. (1)
California Institute of Technology (5)
California State University San Marcos Corporation (7)
California State University, Channel Islands (3)
Calimmune, Inc. (1)
Capricor, Inc (2)
Cedars-Sinai Medical Center (45)
Cellerant Therapeutics, Inc. (1)
Cellular Biomedicine Group, Inc. (1)
Cellular Dynamics International (1)
Celularity Inc. (1)
Chardan (1)
Charles R. Drew University of Medicine and Science (1)
Children’s Hospital of Los Angeles (18)
Children’s Hospital of Orange County (2)
Children’s Neurobiological Solutions (CNS) Foundation (1)
City College Of San Francisco (3)
City of Hope, Beckman Research Institute (59)
Combangio, Inc. (1)
Cytonus Therapeutics, Inc. (1)
Defined Bioscience, Inc. (1)
Elpida Therapeutics (1)
Escape Therapeutics, Inc (1)
Eureka Therapeutics, Inc. (1)
EVERSANA (1)
ExCellThera Inc. (1)
Excision BioTherapeutics (1)
Fate Therapeutics, Inc. (2)
Fluidigm Corporation (2)
Forty Seven Inc. (2)
FUJIFILM Cellular Dynamics (1)
Gamma Medica-Ideas, Inc. (1)
Genascence Corporation (1)
Geron Corporation (2)
Gladstone Institutes, J. David (39)
Global Genes (1)
GMR Epigenetics (1)
Gordon Research Conferences (3)
Greenstone Biosciences, Inc. (3)
HEALIOS NA, Inc. (1)
Humacyte, Inc. (2)
Human BioMolecular Research Institute (4)
Human Organ Project (1)
Humboldt State University Sponsored Programs Foundation (4)
ImmPACT-Bio, Inc. (1)
Immune-Onc Therapeutics (1)
ImmunoCellular Therapeutics (1)
ImmunoVec (3)
Immusoft Corporation (2)
Int. Soc. for Cell Gene Ther. (1)
Intact Therapeutics, Inc. (1)
International Alliance for Biological Standardization (1)
International Society for Experimental Hematology (1)
International Society for Stem Cell Research (6)
International Symposium on Neural Regeneration, Inc. (1)
iPierian, Inc. (2)
IQVIA, Inc. (2)
Jackson Labs (1)
Jasper Therapeutics, Inc. (1)
jCyte, Inc (2)
JDRF International (2)
Juvena Therapeutics Inc. (1)
Kenai Therapeutics (1)
Keystone Symposia on Molecular and Cellular Biology (3)
La Jolla Institute for Allergy and Immunology (1)
Lineage Cell Therapeutics, Inc. (3)
Loma Linda University (2)
Ludwig Institute for Cancer Research (3)
Lundquist Institute for Biomedical Innovation at Harbor – UCLA Medical Center (5)
Luxa Biotechnology (1)
Mahzi Therapeutics (2)
MAX BioPharma, Inc. (1)
Medeor Acquisition Corp. (1)
Midwinter Conference of Immunologists (3)
Minutia, Inc. (2)
MiraCosta College (1)
Mohammad Pashmforoush (1)
Mosaic Event Management, Inc. (1)
MyoGene Bio LLC (1)
Nammi Therapeutics, Inc. (1)
Nanotools Bioscience (1)
Navega Therapeutics (1)
Neurona Therapeutics (5)
Nexcella, Inc. (1)
Nohla Therapeutics Inc (1)
Novoglia, Inc. (2)
Numerate, Inc. (1)
OCTANe Foundation for Innovation (1)
Ocular Research Symposia Foundation, Inc. (1)
OncoMed Pharmaceuticals, Inc. (1)
Orchard Therapeutics plc (1)
Organos, Inc. (1)
Ossium Health, Inc. (1)
Palo Alto Veterans Institute for Research (6)
Parkinson’s Institute (5)
Pasadena City College (3)
Pathways to Stem Cell Science (1)
Poseida Therapeutics, Inc. (2)
Rampart Bioscience (1)
RARE-X (1)
Ray Therapeutics, INC (2)
Regencor, Inc. (1)
Regenerative Patch Technologies LLC (1)
Rejuvenate Bio (1)
Rejuvenation Technologies, Inc. (1)
Replay Holdings, Inc (1)
Research for Cure (1)
Reza Ardehali (1)
Rocket Pharmaceuticals, Inc. (3)
Rubedo Life Sciences Inc. (1)
Rumi Scientific CA (1)
RUNX1 Research Program (1)
Salk Institute for Biological Studies (25)
Samumed, LLC (1)
San Diego State University Foundation (5)
San Francisco State University (4)
SanBio, Inc. (1)
Sanford Burnham Prebys Medical Discovery Institute (28)
Sanford Consortium for Regenerative Medicine (8)
Sangamo BioSciences, Inc. (2)
Scaled Biolabs Inc. (1)
Scripps Health (5)
Scripps Research Institute (29)
Semma Therapeutics (1)
Senti Biosciences, Inc. (1)
Siren Biotechnology, Inc. (1)
SJSU Research Foundation (3)
Solano Community College (1)
St. Jude Children’s Research Hospital (1)
Stanford University (179)
StemCells, Inc. (3)
Summit for Stem Cell Foundation (1)
SynGAP Research Fund (1)
Tachyon Therapeutics, Inc (1)
Tenaya Therapeutics, Inc. (1)
The American Society of Gene & Cell Therapy (1)
The Biomedical Engineering Society (1)
The Regents of the University of California on behalf of its Riverside Campus (11)
The Scintillon Institute (2)
The Stone Research Foundation for Sports Medicine and Arthritis (1)
The University Corporation at California State University, Northridge (4)
Tippi C. Mackenzie (1)
Tr1X Inc. (1)
TriFoil Imaging, Inc. (1)
UCSF Benioff Children’s Hospital Oakland (8)
University of California, Berkeley (34)
University of California, Davis (77)
University of California, Irvine (72)
University of California, Los Angeles (163)
University of California, Merced (8)
University of California, San Diego (138)
University of California, San Francisco (123)
University of California, Santa Barbara (14)
University of California, Santa Cruz (16)
University of Southern California (53)
Vala Sciences, Inc. (1)
Vertuis Bio, Inc. (1)
ViaCyte, Inc. (9)
VistaGen Therapeutics, Inc. (1)
Vitabolus, Inc. (1)
Vitalant Research Institute (6)
VxBiosciences inc. (1)
Wake Forest University Health Sciences (1)
Western University of Health Sciences (1)
X-Therma Inc. (1)
Zenobia Therapeutics (1)
Program Type
(All)
Clinical (172)
Discovery (718)
Education (326)
Infrastructure (104)
Translation (156)
Grant Type
(All)
Accelerated Development Pathway I (1)
Accelerating Center (1)
Alpha Stem Cell Clinics (3)
Alpha Stem Cell Clinics Network Expansion (12)
Basic Biology I (12)
Basic Biology II (16)
Basic Biology III (27)
Basic Biology IV (28)
Basic Biology V (28)
Bridges (16)
Bridges (29)
Clinical Trial Stage Projects (3)
Clinical Trial Stage Projects (92)
COMPASS Training Grant (16)
Comprehensive Grant (29)
Conference (81)
Conference – 2024 CIRM Trainee Network Conference (1)
Conference – Lung Regenerative Medicine Workshop (1)
Conference – Manage a Symposium on Pluripotent Stem Cell Manufacturing (1)
Conference – Manage The 2016 Bridges And SPARK Annual Meetings (1)
Conference – Manage The Bridges Annual Meeting (4)
Conference – Manage The SPARK Annual Meeting (7)
Conference – The 2016 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2017 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2018 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The 2019 Alpha Stem Cell Clinic Annual Symposium (1)
Conference – The Alpha Stem Cell Clinic Annual Symposium (2)
Conference – The 2020 Grantee Meeting (1)
Conference II (84)
Creativity Awards (9)
Cure Sickle Cell Initiative Clinical Trial Stage Projects (3)
Diagnostic Translational Research Projects (3)
Discovery Research Projects (12)
Discovery Research Projects (1)
Disease Team Planning (22)
Disease Team Research I (15)
Disease Team Therapy Development – Research (12)
Disease Team Therapy Development III (6)
Disease Team Therapy Planning I (19)
Early Translational from Disease Team Conversion (3)
Early Translational I (16)
Early Translational II (24)
Early Translational III (21)
Early Translational IV (14)
Foundation – Discovery Stage Research Projects (39)
Genomics Centers of Excellence Awards (R) (3)
hiPSC Derivation (1)
hPSC Repository (1)
Inception – Discovery Stage Research Projects (39)
iPSC Consortia Award (1)
Late Stage Preclinical Projects (49)
Major Facilities (12)
Manufacturing Network Grant (9)
Medical Device Translational Research Projects (1)
New Cell Lines (18)
New Faculty I (26)
New Faculty II (24)
New Faculty Physician Scientist (15)
Patent Assistance Fund Awards (8)
Preclinical Development Awards (7)
Progression Award – Discovery Stage Research Projects (8)
Quest – Discovery Stage Research Projects (144)
Research Leadership (14)
Research Training Grant (18)
Research Training II (17)
SEED Grant (74)
Shared Labs (34)
SPARK (18)
Strategic Partnership I (2)
Strategic Partnership II (1)
Strategic Partnership III Track A (2)
Targeted Clinical Development (1)
Therapeutic Translational Research Projects (81)
Therapeutic Translational Research Projects (1)
Tissue Collection for Disease Modeling (7)
Tool Translational Research Projects (7)
Tools and Technologies I (23)
Tools and Technologies II (20)
Tools and Technologies III (22)
Training Grant I-1 (8)
Training Grant I-2 (5)
Training Grant I-3 (3)
Translating Center (1)
Transplantation Immunology (20)
Human Stem Cell Use
(All)
Adult or Tissue Stem Cell (319)
Cancer Stem Cell (46)
Directly Reprogrammed Cell (11)
Embryonic Stem Cell (389)
iPS Cell (302)
N/A (405)
Other (11)
SCNT (2)
Somatic Cell (30)
Vital Research Opportunity (3)
Cell Line Generation
(All)
Adult or Tissue Stem Cell (61)
Cancer Stem Cell (12)
Directly Reprogrammed Cell (2)
Embryonic Stem Cell (52)
iPS Cell (132)
N/A (1048)
Other (9)
SCNT (2)
Collaborative Funder
(All)
Andalusia, Spain (1)
Australia (3)
Canada (2)
France (1)
Germany (10)
Japan (1)
NIH (3)
United Kingdom (3)
Victoria, Australia (6)
Award Status
(All)
Active (346)
Closed (1109)
Pre-Active (21)
Institution
Researcher name
Grant Type
Grant Title
Award Value
Stanford University
Dr. Joseph C. Wu
Conference II
Stanford Drug Discovery Symposium 2024
$15,000
University of California, San Diego
Dr. Adam Engler
Conference II
BIC 2024 – 24th Annual UC Systemwide Symposium on Bioengineering at UC San Diego
$50,000
University of California, Berkeley
Dr. Regis Kelly
Conference II
Immunotherapy of Brain Disorders
$23,376
Novoglia, Inc.
Dr. Sunil Gandhi Ph.D
Conference II
ALSP Community Conference: Insights and Potential of Cell-Based Therapies for the Treatment of Leukodystrophies
$48,500
University of Southern California
Dr. Yang Chai
Conference II
2023 Dental, Oral, & Craniofacial Tissue Regeneration Consortium (DOCTRC) 4th Annual Joint Retreat/Conference
$47,538
Children’s Hospital of Los Angeles
Alan S Wayne
Conference II
The American Society for Transplantation and Cellular Therapy (ASTCT)/The European Society for Blood and Marrow Transplantation (EBMT) 6th International Conference on Relapse after Transplant and Cellular Therapy
$50,000
Global Genes
Nicole Boice
Conference II
Global Genes Rare Advocacy Summit
$50,000
Stanford University
Dr Ngan F Huang
Conference II
Bay Area Stanford Regenerative Medicine Conference for Students—A TERMIS-AM Ambassador’s Conference
$3,320
Fate Therapeutics, Inc.
Bob Valamehr
Clinical Trial Stage Projects
A Phase 1 Study of FT819 in Participants with Moderate to Severe Active Systemic Lupus Erythematosus
$7,934,448
Senti Biosciences, Inc.
Rochelle Emery
Clinical Trial Stage Projects
Selective, Off-the-Shelf Logic Gated CAR NK Cell Therapy Targeting CD33 and/or FLT3 Expressing Hematologic Malignancies
$8,000,000
ImmPACT-Bio, Inc.
DR Jonathan Benjamin
Clinical Trial Stage Projects
A phase 1/2 study to evaluate a bispecific CD19/CD20-directed CAR T cell, in refractory lupus nephritis and systemic lupus erythematosus
$8,000,000
University of California, San Francisco
Dr. Hideho Okada
Clinical Trial Stage Projects
Phase 1 Study of Autologous E-SYNC T Cells in Adult Participants with EGFRvIII+ Glioblastoma
$10,927,618
Aspen Neuroscience
Dr. Edward Wirth III
Clinical Trial Stage Projects
Phase 1/2a Dose Escalation Study of ANPD001 in Sporadic Parkinson Disease
$8,000,000
Allogene Therapeutics
Dr. John Le Gall
Clinical Trial Stage Projects
A PHASE 1B STUDY EVALUATING THE SAFETY AND EFFICACY OF AN ALLOGENEIC CELL THERAPY IN SUBJECTS WITH CLEAR CELL RENAL CELL CARCINOMA (ccRCC)
$15,000,000
University of California, San Francisco
Noriyuki Kasahara
Clinical Trial Stage Projects
A Phase I/IIa Study to Evaluate the Efficacy of Toca 511/Toca FC with Standard of Care Therapy in Newly Diagnosed High Grade Glioma
$11,807,220
Luxa Biotechnology
Dr. Jeffrey H Stern
Clinical Trial Stage Projects
RPESC-RPE-4W Therapy for dry Age-related Macular Degeneration
$4,009,675
Rocket Pharmaceuticals, Inc.
Dr. Jonathan Schwartz
Clinical Trial Stage Projects
A Phase 2 Study Evaluating the Efficacy and Safety of IV Administered rAAV9 Vector Containing RP-A501 in Male Patients with Danon Disease
$5,808,735
University of California, Davis
Dr. Diana L. Farmer
Clinical Trial Stage Projects
The CuRe Trial: Cellular Therapy for In Utero Repair of Myelomeningocele
$8,996,477
City of Hope, Beckman Research Institute
Elizabeth Budde
Clinical Trial Stage Projects
Phase I Study of Chimeric Antigen Receptor Engineered T Cells targeting CD33 for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
$11,983,547
Stanford University
Dr. Reena Parada Thomas
Clinical Trial Stage Projects
Phase I Trial of Locoregionally Delivered Autologous B7-H3 CAR T Cells (B7-H3CART) in Adults with Recurrent Glioblastoma Multiforme
$11,999,991
University of California, San Diego
Prof. Olivia Kim-McManus
Clinical Trial Stage Projects
Personalized antisense oligonucleotide therapy for rare pediatric genetic disease: SCN2A
$960,713
Stanford University
Anusha Kalbasi
Clinical Trial Stage Projects
Stem-Derived IL13Ra2 Chimeric Antigen Receptor T cells for Patients with Melanoma and Advanced Solid Tumors
$10,211,085
Regenerative Patch Technologies LLC
Dr Jane S Lebkowski
Clinical Trial Stage Projects
A Phase 2b, Randomized, Assessor-Masked Clinical Trial to Assess the Safety and Efficacy of the CPCB-RPE1 Implant in Subjects with Geographic Atrophy
$12,373,748
City of Hope, Beckman Research Institute
Dr. Angelo Manuel Almeida Cardoso Ph.D., MD
Clinical Trial Stage Projects
Evaluation of Safety and Feasibility of Cytomegalovirus-Specific, Anti-HIV Chimeric Antigen Receptor (CMV/HIV-CAR) T Cells in People with HIV
$11,299,976
Combangio, Inc.
R. Kim Brazzell
Clinical Trial Stage Projects
Phase 2b Clinical Study of KPI-012 Topical Ophthalmic Human Mesenchymal Stem Cell Secretome for the Treatment of Persistent Corneal Epithelial Defect
$15,000,000
Immusoft Corporation
Dr Robert Hayes
Clinical Trial Stage Projects
A Phase I Open Label Study to Evaluate the Safety and Tolerability of ISP-001 in Patients with Mucopolysaccharidosis Type 1
$8,000,000
Eureka Therapeutics, Inc.
Pei Wang
Clinical Trial Stage Projects
Autologous ARTEMIS® T Cells to Treat Refractory/Relapsed Pediatric Liver Cancer
$10,600,072
Stanford University
Dr. Matthew H Porteus
Clinical Trial Stage Projects
Reduced intensity conditioning with JSP191 prior to TCRαβ+ T-cell/CD19+ B-cell depleted hematopoietic stem cell transplant for Fanconi Anemia patients
$10,642,420
Angiocrine Bioscience, Inc.
Dr. Paul Finnegan
Clinical Trial Stage Projects
AB-205-301 Phase 3 Trial and Related Activities to Support Clinical Development of AB-205
$10,930,014
Tachyon Therapeutics, Inc
Ivan King
Clinical Trial Stage Projects
TACH101: A Potent, First-In-Class KDM4 Inhibitor for Advanced Cancers
$6,862,609
Genascence Corporation
Dr. Thomas W Chalberg Jr.
Clinical Trial Stage Projects
A Phase 1b, Randomized, Blinded, Placebo-Controlled Dose-Ranging Study of GNSC-001 Evaluating Safety, Pharmacodynamics, and Biomarkers in Knee OA
$11,637,194
City of Hope, Beckman Research Institute
Ryotaro Nakamura
Clinical Trial Stage Projects
Treatment of Severe Aplastic Anemia by induction of mixed chimerism using CD4+ T cell depleted haploidentical donor stem cell transplant
$9,054,216
Neurona Therapeutics
Dr. Cory R Nicholas
Clinical Trial Stage Projects
Phase 1/2 Study of NRTX-1001 Neural Cell Therapy in Subjects with Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy
$7,999,999
Stanford University
Alice Bertaina
Clinical Trial Stage Projects
Sequential same donor αβdepleted-HSCT from an HLA-partially matched donor allowing immunosuppression free kidney transplant
$11,998,188
Excision BioTherapeutics
William Kennedy
Clinical Trial Stage Projects
Phase 1 Clinical research program for functional cure of HIV with EBT-101, in-vivo gene therapy
$6,852,486
Wake Forest University Health Sciences
James Yoo
Clinical Trial Stage Projects
Phase I Treatment of Urethral Strictures in Humans
$3,841,593
City of Hope, Beckman Research Institute
Dr Jana Portnow
Clinical Trial Stage Projects
A Phase I Study of Multiple doses of NSC-Based Oncolytic Virotherapy Administered Intracerebrally to Patients with Recurrent High-Grade Gliomas
$11,999,984
Stanford University
Dr. Rosa Bacchetta
Clinical Trial Stage Projects
Phase 1 Study of Autologous CD4LVFOXP3 in Participants with IPEX Syndrome
$11,999,179
University of California, Davis
Peter C Belafsky
Clinical Trial Stage Projects
A Double-Blind Randomized Placebo-Controlled Investigation of Autologous Muscle Derived Progenitor Cells for the Treatment of Dysphagia
$11,015,936
BioEclipse Therapeutics INC.
Dr. Pamela Reilly Contag
Clinical Trial Stage Projects
PHASE 1, OPEN LABEL, DOSE-ESCALATION STUDY OF CRX100 IN PATIENTS WITH ADVANCED SOLID TUMORS
$7,999,689
Stanford University
Crystal Mackall
Clinical Trial Stage Projects
Phase 1 Clinical Trial of Autologous GD2 Chimeric Antigen Receptor T Cells for Diffuse Intrinsic Pontine Gliomas and Spinal Diffuse Midline Glioma
$11,998,310
Stanford University
Dr. Joseph C. Wu
Clinical Trial Stage Projects
A Phase I, Pilot Study of Human Embryonic Stem Cell-Derived Cardiomyocytes in PaTients with ChrOnic Ischemic Left VentRicular Dysfunction (HECTOR)
$6,987,507
Stanford University
Dr. Matthew H Porteus
Clinical Trial Stage Projects
Phase 1/1b study of T-allo10 infusion after HLA-partially matched abdepleted-HSCT in children and young adults with hematologic malignancies.
$10,563,822
Cedars-Sinai Medical Center
Clive Svendsen
Clinical Trial Stage Projects
CNS10-NPC-GDNF delivered into the motor cortex for the treatment of ALS
$11,990,372
Stanford University
Dr. Gary Steinberg
Clinical Trial Stage Projects
Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects with Chronic Ischemic Subcortical Stroke
$11,998,988
City of Hope, Beckman Research Institute
Dr. Leo D Wang
Clinical Trial Stage Projects
Phase I Study of IL13Rα2-Targeting CAR T Cells After Lymphodepletion for Children with Refractory or Recurrent Malignant Brain Tumors
$8,401,309
University of California, San Francisco
Steven G. Deeks
Clinical Trial Stage Projects
Anti-HIV duoCAR-T cell therapy for HIV infection
$8,970,732
Brain Neurotherapy Bio
Krystof S. Bankiewicz
Clinical Trial Stage Projects
A Phase 1b Safety Study for MRI guided delivery of AAV2-GDNF for the treatment of Parkinson’s disease
$5,510,462
University of California, Los Angeles
Dr. Sophie X Deng
Clinical Trial Stage Projects
Safety and Feasibility of Cultivated Autologous Limbal Stem Cells for Limbal Stem Cell Deficiency
$10,301,486
Cedars-Sinai Medical Center
Clive Svendsen
Clinical Trial Stage Projects
Clinical Study to Assess Safety and Efficacy of Subretinal Injection of Human Neural Progenitor Cells for Treatment of Retinitis Pigmentosa
$10,444,063
« Previous
1
2
3
4
5
6
7
Next »